(4R,4'R)-4,4'-DIPHENYL-4,4',5,5'-TETRAHYDRO-2,2'-BIOXAZOLE, 95%, 250mg

4-Difluoromethoxy-3-methoxy-benzoic acid methyl ester, 97%, 5g

Bicyclo[4.2.0]octa-1,3,5-triene-3-methanol, 97%, 25g

[2-(8-quinolinyloxy)ethyl]amine dihydrochloride, 95.0%, 10g

LIDOCAINE HCL, 97.0%, 100g

3-Cyanobenzohydrazide, 95.0%, 100mg

N'-hydroxynaphthalene-1-carboximidamide, 95.0%, 1g

4,5-Dimethoxy-1-benzocyclobutenecarbonitrile>98.0%(HPLC)(N)1g

2-((tert-Butoxycarbonyl)amino)-5-(trifluoromethyl)benzoic acid, 97%, 1g

2-(2-Acetylphenoxy)acetic acid, 97%, 5g

1-Butoxy-2,3,4-trifluorobenzene, 95.0%, 5g

bScope BS.1152-EPLPH for phase contrast. Biocular with HWF 10x/20 mm eyepieces and Quadruple revolver E-plan Phase 10/20/S40 S100x

2,6-Bis(benzyloxy)benzonitrile, 97%, 5g